Areas of Activity

Contact us

Updates

Toshikazu Otani, MD, Director of  Urology at  CHUBU ROSAI HOSPITAL, Japan, will present a poster (#406) entitled: "ED Treatment using Second Generation Technology of LI-ESWT" at the 20th World Meeting on Sexual Medicine and Global Chinese Andrology and Sexual Medicine Congress. The Congress will take place in Beijing, China from September 22-25, 2016

The symposium will take place in the framework of the National Congress of Urology.

Journal of Sexual Medicine, June 2016, published the Clinical Data of Prof. Amado Bechara (University of Buenos Aires), which presents the long term success of treatment provided to Non-Responder ED patients treated with Renova Linear Shockwave Therapy.

Direx Systems Corp has been selected for the 2016 Best of Canton Award in the Instrument Manufacturers category by the Canton Award Program.

The latest write up on shockwave therapy for ED, is found in Folha de Sao Paulo,  which has the biggest circulation among the largest Brazilian newspapers and is regarded as one of the most influential daily news vehicles in Brazil*.

Direx Argentina (DA), a member of DirexGroup, has reached its 10-year anniversary as a leading provider of innovative devices in the field of urology.

Low Intensity shockwaves technique was presented in Oviedo in the auditorium of the College of Physicians of Asturias by a group of specialists where Renova's Linear technology was introduced. Increasingly, experts claim that erection problems, caused by the lack of supply of blood to the penis, "can be a red flag for cardiovascular disease, stroke or worse".

Dr. Otani, et al, of Chubu Rousai HP of Nagoya, Japan, presented his abstract at the 103rd Annual Meeting of the Japanese Urological Association which took place April 18-21, 2015 in Kanazawa, Japan.

Prof Puppo and Dr. Casarico, from Italy, will be presenting their

A recent study published in Archivos Españoles de Urologia, validates marked results of effectiveness and safety of LIESWT on patients with ED who have failed to respond to PDE5i treatment. Drs. Bechara, Casabe, De Bonis and Nazar from Buenos Aires Argentina , conclude that over 50% reacted positively to the treatment restoring patient's PDE5i response.

Page 5 of 9

Contact Us

© 2024 DirexGroup. All Rights Reserved.